| Literature DB >> 33294774 |
Anthony Culos1,2,3, Amy S Tsai1,3, Natalie Stanley1,2, Martin Becker1,2, Mohammad S Ghaemi1,2,4, David R McIlwain5, Ramin Fallahzadeh1,2, Athena Tanada1,2, Huda Nassar1,2, Camilo Espinosa1,2, Maria Xenochristou1,2, Edward Ganio1, Laura Peterson1,6, Xiaoyuan Han1, Ina A Stelzer1, Kazuo Ando1, Dyani Gaudilliere1, Thanaphong Phongpreecha1,2,7, Ivana Marić1,6, Alan L Chang1,2, Gary M Shaw6, David K Stevenson6, Sean Bendall7, Kara L Davis6, Wendy Fantl5,8,9, Garry P Nolan7, Trevor Hastie2,10, Robert Tibshirani2,10, Martin S Angst1,11, Brice Gaudilliere1,6,11, Nima Aghaeepour1,2,6,11.
Abstract
The dense network of interconnected cellular signalling responses that are quantifiable in peripheral immune cells provides a wealth of actionable immunological insights. Although high-throughput single-cell profiling techniques, including polychromatic flow and mass cytometry, have matured to a point that enables detailed immune profiling of patients in numerous clinical settings, the limited cohort size and high dimensionality of data increase the possibility of false-positive discoveries and model overfitting. We introduce a generalizable machine learning platform, the immunological Elastic-Net (iEN), which incorporates immunological knowledge directly into the predictive models. Importantly, the algorithm maintains the exploratory nature of the high-dimensional dataset, allowing for the inclusion of immune features with strong predictive capabilities even if not consistent with prior knowledge. In three independent studies our method demonstrates improved predictions for clinically relevant outcomes from mass cytometry data generated from whole blood, as well as a large simulated dataset. The iEN is available under an open-source licence.Entities:
Year: 2020 PMID: 33294774 PMCID: PMC7720904 DOI: 10.1038/s42256-020-00232-8
Source DB: PubMed Journal: Nat Mach Intell ISSN: 2522-5839